Publications by authors named "Hahn Khuu"

Claim this Profile
I
Induction of Immune Response after Allogeneic Wilms' Tumor 1 Dendritic Cell Vaccination and Donor Lymphocyte Infusion in Patients with Hematologic Malignancies and Post-Transplantation Relapse.
Nirali N Shah, David M Loeb, Hahn Khuu, David Stroncek, Tolu Ariyo

Biol Blood Marrow Transplant· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term outcome of fludarabine-based reduced-intensity allogeneic hematopoietic cell transplantation for debilitating paroxysmal nocturnal hemoglobinuria.
Jeremy Pantin, Xin Tian, Nancy Geller, Catalina Ramos, Lisa Cook, Hahn Khuu

Biol Blood Marrow Transplant· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.
Jeremy Pantin, Xin Tian, Avni A Shah, Roger Kurlander, Catalina Ramos, Hahn Khuu

Am J Hematol· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 clinical trial of rapamycin-resistant donor CD4+ Th2/Th1 (T-Rapa) cells after low-intensity allogeneic hematopoietic cell transplantation.
Daniel H Fowler, Miriam E Mossoba, Seth M Steinberg, David C Halverson, David Stroncek, Hahn M Khuu

Blood· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.
Nancy M Hardy, Vicki Fellowes, Jeremy J Rose, Jeanne Odom, Stefania Pittaluga, Hahn M Khuu

Blood· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selectively T cell-depleted allografts from HLA-matched sibling donors followed by low-dose posttransplantation immunosuppression to improve transplantation outcome in patients with hematologic malignancies.
Stephan Mielke, Zachariah A McIver, Aarthy Shenoy, Vicki Fellowes, Hahn Khuu

Biol Blood Marrow Transplant· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immune reconstitution in recipients of photodepleted HLA-identical sibling donor stem cell transplantations: T cell subset frequencies predict outcome.
Zachariah A McIver, Jan J Melenhorst, Andrew Grim, Nicholas Naguib, Gerrit Weber, Hahn Khuu

Biol Blood Marrow Transplant· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase I trial of adoptive cell transfer with mixed-profile type-I/type-II allogeneic T cells for metastatic breast cancer.
Nancy M Hardy, Miriam E Mossoba, Seth M Steinberg, Vicki Fellowes, Xiao-Yi Yan, Hahn M Khuu

Clin Cancer Res· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis